Table 1 Demographic and baseline clinical characteristicsa
Partial Oral Therapy | All Intravenous Therapy | Total | ||
|---|---|---|---|---|
Characteristic | (n = 148) | (n = 101) | (N = 249) | |
Age, median (IQR) | 55 (42–62) | 57 (48–65) | 56 (44–63) | |
Male sex | 115 (78) | 70 (69) | 185 (74) | |
Required intensive care unit stayb | 14 (10) | 33 (33) | 47 (19) | |
Comorbid conditions | ||||
HIV infection | 2 (1) | 5 (5) | 7 (3) | |
Cardiovascular disease | 64 (43) | 51 (51) | 115 (46) | |
Diabetes mellitus | 68 (46) | 38 (38) | 106 (43) | |
Dialysis-dependent | 5 (3) | 11 (11) | 16 (6) | |
Chronic liver disease | 20 (14) | 20 (20) | 40 (16) | |
Antimicrobial prophylaxis prior to admission | 3 (2) | 1 (1) | 4 (2) | |
Immunosuppression | 2 (1) | 4 (4) | 6 (2) | |
Trauma within 30 days | 1 (1) | 2 (2) | 3 (1) | |
Surgery within 30 days | 12 (8) | 10 (10) | 22 (9) | |
Experiencing homelessness | 42 (28) | 25 (25) | 67 (27) | |
Active substance use disorderc | 82 (55) | 43 (43) | 125 (50) | |
Injection drug used | 26 (18) | 17 (17) | 43 (17) | |
Initiated or maintained on MOUDe | 18 (12) | 16 (16) | 34 (14) | |
QSOFA scoref | ||||
0 | 99 (67) | 46 (46) | 145 (58) | |
1 | 46 (31) | 37 (37) | 83 (33) | |
2 | 2 (1) | 13 (13) | 15 (6) | |
3 | 1 (1) | 5 (5) | 6 (2) | |